Azelnidipine, a novel calcium channel blocker, ameliorates severity of colitis in DSS induced colitis in mice possibly by modulating tissue levels of TNF-alpha and IL-6


Creative Commons License

KAV T., AKYOL A., KAHRAMANOĞLU AKSOY E., ÖZER C., TORGUTALP M., SİVRİ B.

12th Congress of ECCO, Barselona, İspanya, 15 Şubat 2017 - 18 Şubat 2018, cilt.11, ss.93-94, (Özet Bildiri)